News

Find News

Filter articles

Showing 71 to 80 of 2673 results

Jazz Pharma buys clinical-stage biotech company

Ireland14-08-2019Sarah Morgan

Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million.

Eli Lilly unit accuses Alzheimer's institute of ‘malicious’ patent prosecution

US14-08-2019Sarah Morgan

Avid Radiopharmaceuticals, a subsidiary of Eli Lilly, has taken the Alzheimer's Institute of America to court over its “malicious” prosecution of a patent infringement case.

Allergan says rivals using trade secrets disclosed by USITC order

US13-08-2019Saman Javed

Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.

Sandoz to appeal against Amgen biosimilar ruling

US13-08-2019Sarah Morgan

Sandoz has confirmed that it plans to appeal against a decision that upheld the validity of two of Amgen’s patents for its arthritis treatment Enbrel, effectively blocking the launch of Sandoz’s biosimilar version.

Fed Circ affirms Eli Lilly victories over cancer drugs

US13-08-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

Bayer buys BlueRock to build cell therapy expertise

Germany, US09-08-2019Sarah Morgan

Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.

NHS to receive £250m for new AI lab

UK08-08-2019Saman Javed

The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

FTC demands Boston Scientific divest business amid $4.2bn deal

US08-08-2019Sarah Morgan

The US Federal Trade Commission is requiring medical device maker Boston Scientific to divest business, as part of a settlement resolving antitrust charges related to its acquisition of UK-based healthcare company BTG.

Akebia Therapeutics and Par Pharma settle Auryxia suit

US07-08-2019Saman Javed

A subsidiary of Akebia Therapeutics has entered into a settlement agreement with Endo-owned Par Pharmaceutical.

Fed Circ backs ITC on E. coli patent dispute

US07-08-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit yesterday, August 6, affirmed a US International Trade Commission decision to uphold a patent related to E. coli bacteria.

Showing 71 to 80 of 2673 results

LSIPR